Tailored IV fluids aim to shield kidneys during heart tests
NCT ID NCT04936607
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a personalized hydration strategy to prevent contrast-induced acute kidney injury (CI-AKI) in adults undergoing coronary angiogram or PCI. Participants receive intravenous saline at rates adjusted based on their heart pressure, contrast dose, and kidney function. The goal is to see if this tailored approach reduces kidney damage and improves overall outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Personalized hydration strategy (intravenous saline adjusted based on heart pressure, contrast dose, and kidney function)
What this could lead to
If successful, this could provide a simple, tailored hydration method to reduce the risk of kidney injury after common heart procedures.
What could go wrong
This is an early-stage trial (Phase NA) with 1158 participants, so results may not apply to all patients. The hydration adjustments are complex and may not prevent kidney injury in everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST INDUCED ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montreal Heart Institute
RECRUITINGMontreal, Quebec, H1T1C8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••